革命性的儿科基因和细胞疗法:基于脂质的纳米粒子在血液疾病中的希望
Fatemeh Zahedipour1, Tahereh Mohammadian Gol1, Silas Wisser1
1University Children's Hospital, Department of Hematology and Oncology, University of Tübingen, Germany.
Current research in translational medicine
|October 11, 2025
概括
基于脂质的纳米颗粒 (LNP) 为基因和细胞疗法提供核酸提供一个多功能和安全的平台,特别是用于儿科应用. 它们的成本效益和可扩展性提高了对遗传疾病和癌症的先进治疗方法的可访问性.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 基因治疗 基因治疗
背景情况:
- 基于脂质的纳米粒子 (LNP) 正在成为核酸的强大输送系统.
- 它们的多功能性和低毒性使它们适合各种治疗应用,包括儿科.
- 以前的成功包括FDA批准的siRNA疗法和mRNA疫苗.
研究的目的:
- 审查LNP在基因和细胞治疗中的应用.
- 专注于NK细胞,T细胞和HSC等初级细胞的临床前应用.
- 突出LNP在儿科医疗保健中的有效性,安全性和变革潜力.
主要方法:
- 在基因和细胞治疗中对LNP应用的文献综述.
- 对初级细胞中LNP递送的临床前数据的分析.
- 评估LNP的安全性和有效性概况.
主要成果:
- 在LNP中,可以有效地将遗传物质 (siRNA,mRNA,pDNA) 传递到目标细胞.
- 临床前研究表明,在原始细胞 (NK,T,HSC) 中具有有前途的疗效和安全性.
- 与病毒载体和电穿孔相比,LNP生产具有可扩展性和成本效益.
结论:
- 在基因和细胞疗法中,LNP代表了显著的进步,特别是在儿科应用中.
- 它们在治疗遗传疾病和癌症方面的潜力是巨大的.
- 临床临床医生准备通过改善治疗可访问性和治疗结果来改变儿科医疗保健.
相关概念视频
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212


